Clinical utility of rapid disk-based combination susceptibility testing in carbapenem-resistant Acinetobacter baumannii infection

Background The clinical utility of in vitro combination susceptibility testing for carbapenem-resistant Acinetobacter baumannii (CRAB) infection remains uncertain. We evaluated the clinical utility of a rapid disk-based combination susceptibility approach. Methods This retrospective single-center study included patients with CRAB infection undergoing disk-based combination susceptibility testing between September 2024 and June 2026. Disk approximation results were compared with checkerboard testing in a selected validation subset. The primary outcome was 30-day all-cause mortality, with day-15 treatment effectiveness as the secondary outcome. Results Seventy-six patients were included. In nine selected isolates, 90 paired isolate–combination assessments showed complete categorical concordance between disk approximation and checkerboard testing after synergy and additivity were grouped as favorable interactions. In day-3 landmark Cox analysis, early favorable-interaction therapy was associated with a lower hazard of 30-day mortality in both univariable and multivariable analyses (adjusted hazard ratio 0.25, 95% CI 0.10–0.63; P = 0.003). Early appropriate therapy showed a protective trend but was not significant after adjustment (adjusted hazard ratio 0.45, 95% CI 0.17–1.15; P = 0.094). Day-15 treatment effectiveness was achieved in 44/76 patients (57.9%). Early favorable-interaction therapy was independently associated with higher odds of day-15 effectiveness (adjusted odds ratio 6.36, 95% CI 2.00–22.99; P = 0.003). Conclusions The disk-based approach showed encouraging agreement with checkerboard testing and can be integrated into routine susceptibility workflows. Early favorable-interaction therapy was associated with lower mortality and better treatment response, supporting the potential clinical utility of rapid disk-based combination susceptibility testing for early treatment optimization in CRAB infection.

Authors

Institutions

Publication Details

Journal
Frontiers in Cellular and Infection Microbiology
Published
2026-11-18
DOI
https://doi.org/10.3389/fcimb.2026.1999081
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical utility of rapid disk-based combination susceptibility testing in carbapenem-resistant Acinetobacter baumannii infection

HuiJuan YAO, Zheng Jiao, Jingxian Liu, BU Shuhong et al.
3 links
Frontiers in Cellular and Infection Microbiology
Antibiotic Resistance in Bacteria
article

Clinical utility of rapid disk-based combination susceptibility testing in carbapenem-resistant Acinetobacter baumannii infection

HuiJuan YAO, Zheng Jiao, Jingxian Liu, BU Shuhong, CHEN Jihui, Xinyi Wang
article en

Abstract

Background The clinical utility of in vitro combination susceptibility testing for carbapenem-resistant Acinetobacter baumannii (CRAB) infection remains uncertain. We evaluated the clinical utility of a rapid disk-based combination susceptibility approach. Methods This retrospective single-center study included patients with CRAB infection undergoing disk-based combination susceptibility testing between September 2024 and June 2026. Disk approximation results were compared with checkerboard testing in a selected validation subset. The primary outcome was 30-day all-cause mortality, with day-15 treatment effectiveness as the secondary outcome. Results Seventy-six patients were included. In nine selected isolates, 90 paired isolate–combination assessments showed complete categorical concordance between disk approximation and checkerboard testing after synergy and additivity were grouped as favorable interactions. In day-3 landmark Cox analysis, early favorable-interaction therapy was associated with a lower hazard of 30-day mortality in both univariable and multivariable analyses (adjusted hazard ratio 0.25, 95% CI 0.10–0.63; P = 0.003). Early appropriate therapy showed a protective trend but was not significant after adjustment (adjusted hazard ratio 0.45, 95% CI 0.17–1.15; P = 0.094). Day-15 treatment effectiveness was achieved in 44/76 patients (57.9%). Early favorable-interaction therapy was independently associated with higher odds of day-15 effectiveness (adjusted odds ratio 6.36, 95% CI 2.00–22.99; P = 0.003). Conclusions The disk-based approach showed encouraging agreement with checkerboard testing and can be integrated into routine susceptibility workflows. Early favorable-interaction therapy was associated with lower mortality and better treatment response, supporting the potential clinical utility of rapid disk-based combination susceptibility testing for early treatment optimization in CRAB infection.

Frontiers in Cellular and Infection MicrobiologyVol. 16
Shanghai Jiao Tong University (CN), XinHua Hospital (CN), Shanghai Chest Hospital (CN)
Good health and well-being
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon